Ad is loading...
OPK
Price
$1.58
Change
+$0.05 (+3.27%)
Updated
Dec 3 closing price
78 days until earnings call
XAIR
Price
$0.55
Change
+$0.04 (+7.84%)
Updated
Dec 3 closing price
64 days until earnings call
Ad is loading...

OPK vs XAIR

Header iconOPK vs XAIR Comparison
Open Charts OPK vs XAIRBanner chart's image
OPKO Health
Price$1.58
Change+$0.05 (+3.27%)
Volume$10.79M
CapitalizationN/A
Beyond Air
Price$0.55
Change+$0.04 (+7.84%)
Volume$2.01M
CapitalizationN/A
OPK vs XAIR Comparison Chart
Loading...
OPK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
OPK vs. XAIR commentary
Dec 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPK is a StrongSell and XAIR is a Buy.

COMPARISON
Comparison
Dec 04, 2024
Stock price -- (OPK: $1.58 vs. XAIR: $0.55)
Brand notoriety: OPK and XAIR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: OPK: 267% vs. XAIR: 210%
Market capitalization -- OPK: $920.03M vs. XAIR: $79.87M
OPK [@Medical Specialties] is valued at $920.03M. XAIR’s [@Medical Specialties] market capitalization is $79.87M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPK’s FA Score shows that 0 FA rating(s) are green whileXAIR’s FA Score has 0 green FA rating(s).

  • OPK’s FA Score: 0 green, 5 red.
  • XAIR’s FA Score: 0 green, 5 red.
According to our system of comparison, XAIR is a better buy in the long-term than OPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OPK’s TA Score shows that 3 TA indicator(s) are bullish while XAIR’s TA Score has 5 bullish TA indicator(s).

  • OPK’s TA Score: 3 bullish, 5 bearish.
  • XAIR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XAIR is a better buy in the short-term than OPK.

Price Growth

OPK (@Medical Specialties) experienced а +1.94% price change this week, while XAIR (@Medical Specialties) price change was -17.99% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.50%. For the same industry, the average monthly price growth was +3.49%, and the average quarterly price growth was +0.55%.

Reported Earning Dates

OPK is expected to report earnings on Feb 20, 2025.

XAIR is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Medical Specialties (+1.50% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPK($920M) has a higher market cap than XAIR($79.9M). OPK YTD gains are higher at: 4.636 vs. XAIR (-72.092). OPK (-65.52M) and XAIR (-67.06M) have comparable annual earnings (EBITDA) . OPK has more cash in the bank: 95.9M vs. XAIR (31.3M). XAIR has less debt than OPK: XAIR (16.9M) vs OPK (327M). OPK has higher revenues than XAIR: OPK (863M) vs XAIR (689K).
OPKXAIROPK / XAIR
Capitalization920M79.9M1,151%
EBITDA-65.52M-67.06M98%
Gain YTD4.636-72.092-6%
P/E Ratio26.11N/A-
Revenue863M689K125,254%
Total Cash95.9M31.3M306%
Total Debt327M16.9M1,935%
FUNDAMENTALS RATINGS
OPK vs XAIR: Fundamental Ratings
OPK
XAIR
OUTLOOK RATING
1..100
714
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
9299
PRICE GROWTH RATING
1..100
5664
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XAIR's Valuation (34) in the null industry is in the same range as OPK (62) in the Biotechnology industry. This means that XAIR’s stock grew similarly to OPK’s over the last 12 months.

OPK's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as XAIR (100) in the null industry. This means that OPK’s stock grew similarly to XAIR’s over the last 12 months.

OPK's SMR Rating (92) in the Biotechnology industry is in the same range as XAIR (99) in the null industry. This means that OPK’s stock grew similarly to XAIR’s over the last 12 months.

OPK's Price Growth Rating (56) in the Biotechnology industry is in the same range as XAIR (64) in the null industry. This means that OPK’s stock grew similarly to XAIR’s over the last 12 months.

OPK's P/E Growth Rating (99) in the Biotechnology industry is in the same range as XAIR (100) in the null industry. This means that OPK’s stock grew similarly to XAIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OPKXAIR
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
OPK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIVI51.060.17
+0.33%
Civitas Resources
ASYS5.710.01
+0.18%
Amtech Systems
CRM331.430.42
+0.13%
Salesforce
NMRK15.30-0.01
-0.07%
Newmark Group
CYH3.40-0.02
-0.58%
Community Health Systems

XAIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XAIR has been loosely correlated with OPK. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XAIR jumps, then OPK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XAIR
1D Price
Change %
XAIR100%
+7.85%
OPK - XAIR
35%
Loosely correlated
+3.27%
KIDS - XAIR
32%
Poorly correlated
+0.96%
SHWGY - XAIR
32%
Poorly correlated
N/A
CERS - XAIR
31%
Poorly correlated
-7.33%
IDXX - XAIR
31%
Poorly correlated
+0.31%
More